Rheumatoid arthritis drug reduces risk of death for severely ill hospitalized Covid-19 patients, researchers say
Tocilizumab, an intravenous anti-inflammatory drug used for rheumatoid arthritis, has been shown to reduce the risk of death for patients…
Continue Reading